PsiF DNA Sacroiliac Joint Stabilization System
Degenerative sacroiliitis and SI joint disruptions
FDA Cleared (510(k))Active
Key Facts
Indication
Degenerative sacroiliitis and SI joint disruptions
Phase
FDA Cleared (510(k))
Status
Active
Company
About Omnia Medical
Omnia Medical is a U.S.-based orthopedic implant company focused on spine and pain intervention, with a commercial portfolio of FDA-cleared devices. The company emphasizes engineering-driven innovation to create reproducible instrumentation for surgeons, targeting improved patient outcomes and cost savings for healthcare systems. Recent milestones include the 2025 FDA clearance and commercial launch of its PsiF DNA SI Joint Stabilization System and the resolution of significant litigation with a competitor. Omnia operates with a direct sales and distributor model, seeking to expand its commercial footprint in the competitive spine device market.
View full company profile